Onchocerciasis

• CLINICAL_TRIALS trial_result · 2017-08-29
  Clinical Trial Update: IVM Alone vs ALB + IVM Against Onchocerciasis [Phase 3]

  A Phase 3 trial comparing ivermectin alone versus albendazole plus ivermectin for onchocerciasis has completed.

• CLINICAL_TRIALS withdrawal · 2012-03-29
  Clinical Trial Update: Pediatric Pharmacokinetics And Safety Study Of Moxidectin [Phase 2]

  Pfizer's Phase 2 pediatric pharmacokinetics and safety study of moxidectin for onchocerciasis has been withdrawn.

• FDA approval · 2008-02-26
  FDA Approved: STROMECTOL — Supplemental Application (Merck Sharp & Dohme LLC)

  FDA approved a supplemental application for Stromectol (ivermectin) filed by Merck Sharp & Dohme LLC, granting changes to the drug's labelin…